Latest News

Ian Flinn, MD, PhD: Bruton's Tyrosine Kinase Therapy Offers Fewer Adverse Events for CLL, SLL

1 hour ago

Dr. Ian Flinn explains that as a Bruton's tyrosine kinase (BTK) therapy, zanubrutinib provides an option with reduced adverse events compared with chemotherapy treatments like venetoclax.

CVD-Related Deaths Surged During First Year of COVID-19 Pandemic

2 hours ago

New data from the AHA 2023 Statistical Update suggest more people died from cardiovascular-related causes in 2020 than in any year since 2003.

Biomarker Predicts Patients at Greater Risk of Worsening Knee Osteoarthritis

3 hours ago

“Our primary motivation was to help develop treatments for people with osteoarthritis that would slow or prevent the disease and be more than painkillers- actually affect the disease process itself,” Virginia Kraus, MD, explains.

Air Pollution in Urban Areas Linked to Asthma, Inflammatory Responses in Children

4 hours ago

The specific mechanisms involved in associations between air pollution and respiratory illness without viral infection are not understood, especially compared with those of respiratory viruses and asthma exacerbation.

Aerobic Exercise Programs May Help Prevent Diabetes in Individuals with Obesity

5 hours ago

The risk of diabetes was reduced by approximately 50% in both the vigorous and moderate aerobic exercise groups compared with the nonexercise group.